N-[4-Fluoro-5-[[2S,4S)-2-Methyl-4-[(5-Methyl-1,2,4-Oxadiazol-3-Yl)Methoxy]-1-Piperidinyl]Methyl]-2-Thiazolyl-Acetamide

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

1 Countries

Phase II

Phase II: 1

Sponsors using this IMP

Eli Lilly & Co. 1

All trials

1 total

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer’s Disease Ended

2024-512295-36-00 Phase II 1 country Eli Lilly & Co.

Showing 1–1 of 1 trials

← All drugs A–Z